Added value of 3D-vision during robotic pancreatoduodenectomy anastomoses in biotissue (LAEBOT 3D2D): a randomized controlled cross-over trial

• Published in: Surgical endoscopy Vol. 35; no. 6; pp. 2928 - 2935
• Main Authors: Zwart, Maurice J. W., Jones, Leia R., Balduzzi, Alberto, Takagi, Kosei, Vanlander, Aude, van den Boezem, Peter B., Daams, Freek, Rosman, Camiel, Lips, Daan J., Moser, Arthur J., Hogg, Melissa E., Busch, Olivier R. C., Stommel, Martijn W. J., Besselink, Marc G.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2021; Springer Nature B.V
• Subjects: Abdominal Surgery; Confidence intervals; Endoscopy; Gastroenterology; Gynecology; Hepatology; Laparoscopy; Medicine; Medicine & Public Health; Pancreatic cancer; Pancreaticoduodenectomy; Proctology; Robotic surgery; Robots; Standard deviation; Statistical methods; Surgeons; Surgery; 3D; Artificial organs; Laparoscopy; OSATS; Robot-assisted surgery
• ISSN: 0930-2794; 1432-2218
• DOI: 10.1007/s00464-020-07732-z

Background We tested the added value of 3D-vision on procedure time and surgical performance during robotic pancreatoduodenectomy anastomoses in biotissue. Robotic surgery has the advantage of articulating instruments and 3D-vision. Consensus is lacking on the added value of 3D-vision during laparoscopic surgery. Given the improved dexterity with robotic surgery, the added value of 3D-vision may be even less with robotic surgery. Methods In this experimental randomized controlled cross-over trial, 20 surgeons and surgical residents from 5 countries performed robotic pancreaticojejunostomy and hepaticojejunostomy anastomoses in a biotissue organ model using the da Vinci® system and were randomized to start with either 3D- or 2D-vision. Primary endpoint was the time required to complete both anastomoses. Secondary endpoint was the objective structured assessment of technical skill (OSATS; range 12–60) rating; scored by two observers blinded to 3D/2D. Results Robotic 3D-vision reduced the combined operative time from 78.1 to 57.3 min (24.6% reduction, p  < 0.001; 20.8 min reduction, 95% confidence intervals 12.8–28.8 min). This reduction was consistent for both anastomoses and between surgeons and residents, p  < 0.001. Robotic 3D-vision improved OSATS performance by 6.1 points (20.8% improvement, p  = 0.003) compared to 2D (39.4 to 45.1 points, ± 5.5). Conclusion 3D-vision has a considerable added value during robotic pancreatoduodenectomy anastomoses in biotissue in both time reduction and improved surgical performance as compared to 2D-vision.